About this event

  • Date and time Thu 12 Mar 2020 from 5:30pm to 11:00pm
  • Location Live stream - online
  • Organised by Ophthalmology

The 2020 Ophthalmology Section's Lang Lecture will be given by Professor Robert MacLaren, an eminent professor at University of Oxford pioneering gene treatments for retinal disease.

Gene therapy for retinal disease is the next class of medicines to become available to patients. Professor MacLaren is a leader in this field and his unique perspective on the subject will be of great interest to Ophthalmologists as well as many other doctors in the fields of genetics and medicine. 

This unique lecture will update you on current progress and future developments of gene therapy for retina diseases.

Meeting topics:

  • To review why the eye is such a good target for gene therapy
  • To review the background research done in this field
  • To evaluate where we are today with gene therapy for the eyes
  • To evaluate where we will be in the next 5 years.
  • Relating all this to patient benefit.

To book to attend the event in London, click here.

There are bursary places available for all Ophthalmology meetings - send your request to ophthalmology@rsm.ac.uk

The Ophthalmology Section would like to thank Bausch + Lomb and Johnson & Johnson for supporting the Academic Year 2019-2020 Programme of Events
Please note that none of the companies listed have had any influence or involvement over the agenda, content or organisation of this meeting.


View the programme

Welcome and introduction

Mr Nicholas Lee, President, Ophthalmology Section, Royal Society of Medicine

New gene therapy treatments for retinal diseases

Professor Robert MacLaren, Professor of Ophthalmology, University of Oxford

Question and answer session
Close of meeting


Live stream - online